Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-11

Clinical Trial Update: Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)

View source ↗

Summary

This completed clinical trial evaluated the antihypertensive efficacy, tolerability, and adherence of the fixed-dose triple combination of amlodipine, indapamid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triplixam (amlodipine/indapamide/perindopril) fixed-dose combination (Amlodipine/Indapamide/Perindopril)

Snippet

Sponsor: Servier Russia | Conditions: Arterial Hypertension, HTN | Status: COMPLETED